EODData

MEMBERSHIP REGISTER LOG IN

FRA, EU6: PDS Biotechnology Corp

05 Nov 2025
LAST:

0.7625

CHANGE:
 0.03		OPEN:
0.7625		HIGH:
0.7625		ASK:
0.0000		VOLUME:
120
CHG(%):
3.85		PREV:
0.7930		LOW:
0.7625		BID:
0.0000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
05 Nov 250.76250.76250.76250.7625120
04 Nov 250.79300.79300.79300.7930120
03 Nov 250.79450.79450.79450.7945120
31 Oct 250.81050.81050.81050.8105120
30 Oct 250.87600.87600.87600.8760120
29 Oct 250.79300.79300.79300.7930120
28 Oct 250.78600.78600.78600.7860120
27 Oct 250.78350.78400.78350.7835120
24 Oct 250.77850.80850.77850.8085120
23 Oct 250.79750.79750.79750.79752.0K

COMPANY PROFILE

Name:PDS Biotechnology Corp
About:PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, developing a pipeline of targeted cancer immunotherapies. The company's lead product candidate is Versamune HPV, which is in phase II clinical trial for the treatment of head and neck, cervical, anal, vaginal, vulvar, and penile cancers. It also develops various product candidates, which are in preclinical trials, including PDS0102, an investigational immunotherapy utilizing tumor-associated and immunologically active T cell receptor gamma alternate reading framed protein for treating acute myeloid leukemia, prostate, and breast cancer; and PDS0103 for ovarian, breast, colorectal, and lung cancers. In addition, the company is developing PDS01ADC, a novel investigational Interleukin 12 fused antibody-drug conjugate, tumor-targeting interleukin 12 immune-cytokine that enhances the proliferation, potency, and longevity of T cells in the tumor microenvironment. Further, the company provides PDS0202, a novel investigational influenza vaccine that protects against the strains predicted to be prevalent in an upcoming flu season. It has a license and collaboration agreements with National Institutes of Health, Merck Eprova AG, The U.S. Department of Health and Human Services, and MSD International GmbH. PDS Biotechnology Corporation was founded in 2005 and is based in Princeton, New Jersey.
Sector:Healthcare
Industry:Biotechnology
Address:303A College Road East, Princeton, NJ, United States, 08540
Website:https://www.pdsbiotech.com
ISIN:US70465T1079
LEI:5493002KU8ACFTSMC935

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:-0.77 
Forward P/E:-0.97 
PEG Ratio:0.09 
Price to Book:2.32 
Return on Assets:-0.42 
Return on Equity:-1.56 
Shares:46.63M 
Market Cap:35.56M 

TECHNICAL INDICATORS

MA5:0.815.9%
MA10:0.805.0%
MA20:0.816.2%
MA50:0.9018.1%
MA100:0.9929.4%
MA200:1.1145.9%
RSI14:39.97 
WPR14:-100.00 
MTM14:-0.04
ROC14:-0.05 
ATR:0.03 
Week High:0.8814.9%
Week Low:0.760.0%
Month High:0.8814.9%
Month Low:0.7645.9%
Year High:2.98290.8%
Year Low:0.760.0%
Volatility:23.77 

RECENT SPLITS

Date Ratio
18 Mar 20191-20